Related Experiment Video
Updated: Nov 2, 2025

Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation
Published on: February 16, 2018
The Role of Microglia in Perioperative Neuroinflammation and Neurocognitive Disorders
Sarah Saxena1,2, Veronique Kruys3, Joseph Vamecq4
1Department of Anesthesia, University Hospital Center (CHU de Charleroi), Charleroi, Belgium.
Abstract:
The aseptic trauma of peripheral surgery activates a systemic inflammatory response that results in neuro-inflammation; the microglia, the resident immunocompetent cells in the brain, are a key element of the neuroinflammatory response. In most settings microglia perform a surveillance role in the brain detecting and responding to "invaders" to maintain homeostasis. However, microglia have also been implicated in producing harm possibly by changing its phenotype from its beneficial, anti-inflammatory state (termed M2) into an injurious pro-inflammatory state (termed M1); it is likely that there are intermediates states between these polar phenotypes and some consider that a gradient exists with a number of intermediates, rather than a strict dichotomy between M1 and M2. In the pro-inflammatory phenotypes, microglia can disrupt synaptic plasticity such as long- term potentiation that can result in disorders of learning and memory of the type observed in Peri-operative Neurocognitive Disorders. Therefore, investigators have sought strategies to prevent microglia from provoking this adverse event in the perioperative period. In preclinical studies microglia can be depleted by removing trophic factors required for its maintenance; subsequent repopulation with a more beneficial microglial phenotype may result in memory enhancement, improved sensory motor function, as well as suppression of neuroinflammatory and oxidative stress pathways. Another approach consists of preventing microglial activation using the non-specific P38 MAP kinase blockers such as minocycline. Perhaps a more physiologic approach is the use of inhibitors of potassium (K+) channels that are required to convert the microglia into an active state. In this context the specific K+ channels that are implicated are termed Kv1.3 and KCa3.1 and high selective inhibitors for each have been developed. Data are accumulating demonstrating the utility of these K+ channel blockers in preventing Perioperative Neurocognitive Disorders.
Insights
Peripheral surgery triggers neuroinflammation via microglia activation, potentially causing cognitive disorders. Inhibiting specific potassium channels (Kv1.3 and KCa3.1) in microglia shows promise for preventing these perioperative neurocognitive disorders.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Peripheral surgery induces systemic inflammation, leading to neuroinflammation.
- Microglia, the brain's immune cells, play a key role in neuroinflammation, potentially shifting from a beneficial (M2) to a harmful (M1) phenotype.
- This shift can disrupt synaptic plasticity, causing learning and memory deficits seen in perioperative neurocognitive disorders.
Purpose of the Study:
- To explore strategies for preventing detrimental microglial activation during the perioperative period.
- To investigate the potential of targeting specific microglial potassium channels (Kv1.3 and KCa3.1) to mitigate neuroinflammation and cognitive decline.
Main Methods:
- Review of preclinical studies on microglial modulation.
- Investigation of non-specific P38 MAP kinase inhibitors (e.g., minocycline).
- Focus on specific potassium channel blockers (Kv1.3 and KCa3.1 inhibitors) as a physiological approach.
Main Results:
- Depleting microglia and repopulating with beneficial phenotypes may improve cognitive and motor functions while reducing neuroinflammation.
- Minocycline, a P38 MAP kinase blocker, can prevent microglial activation.
- Selective inhibitors of Kv1.3 and KCa3.1 potassium channels are effective in preclinical models.
Conclusions:
- Targeting microglial potassium channels represents a promising therapeutic strategy.
- Inhibitors of Kv1.3 and KCa3.1 channels may prevent perioperative neurocognitive disorders.
- Further research is warranted to translate these findings into clinical practice.

